132 related articles for article (PubMed ID: 18070201)
1. Anastrozole-induced subacute cutaneous lupus erythematosus.
Trancart M; Cavailhes A; Balme B; Skowron F
Br J Dermatol; 2008 Mar; 158(3):628-9. PubMed ID: 18070201
[No Abstract] [Full Text] [Related]
2. Anastrozole-induced subacute cutaneous lupus erythematosus.
Fisher J; Patel M; Miller M; Burris K
Cutis; 2016 Aug; 98(2):E22-6. PubMed ID: 27622265
[TBL] [Abstract][Full Text] [Related]
3. Subacute cutaneous lupus erythematosus in a leuprorelin-treated patient with prostate carcinoma.
Wiechert A; Tüting T; Bieber T; Haidl G; Wenzel J
Br J Dermatol; 2008 Jul; 159(1):231-3. PubMed ID: 18476960
[No Abstract] [Full Text] [Related]
4. Fulvestrant versus anastrozole as second-line treatment of advanced breast cancer in postmenopausal women.
Vergote I;
Eur J Cancer; 2002 Nov; 38 Suppl 6():S57-8. PubMed ID: 12409076
[No Abstract] [Full Text] [Related]
5. Successful desensitisation to Anastrozole.
Rodrigues J; Malheiro D; Botelho C; Cruz MC; Castel-Branco MG
Allergol Immunopathol (Madr); 2009; 37(1):50-1. PubMed ID: 19268063
[No Abstract] [Full Text] [Related]
6. Subacute Cutaneous Lupus Erythematosus Induced by Mitotane.
Mayor-Ibarguren A; Roldán-Puchalt MC; Gómez-Fernández C; Albízuri-Prado F; Álvarez-Escola C
JAMA Dermatol; 2016 Jan; 152(1):109-11. PubMed ID: 26444320
[No Abstract] [Full Text] [Related]
7. Breast cancer prevention.
Thornton H
Br J Gen Pract; 2003 Feb; 53(487):150. PubMed ID: 12817365
[No Abstract] [Full Text] [Related]
8. [A case of crescentic glomerulonephritis developed under oral anastrozole treatment].
Yoshimoto S; Nakatani K; Maruyama N; Fujiki K; Nakano T; Ueshima K; Fujimoto T; Oka H; Ishikawa H; Inoue F
Gan To Kagaku Ryoho; 2013 Feb; 40(2):267-70. PubMed ID: 23411970
[TBL] [Abstract][Full Text] [Related]
9. Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.
Karagöz B; Ayata A; Bilgi O; Uzun G; Unal M; Kandemir EG; Ozgün A; Türken O
Onkologie; 2009 Jul; 32(7):421-3. PubMed ID: 19556821
[TBL] [Abstract][Full Text] [Related]
10. Severe disabling tendinopathy caused by anastrazole.
Martens HA; Schröder CP; van der Eerden PJ; Willemse PH; Posthumus MD
Rheumatology (Oxford); 2007 Oct; 46(10):1619-21. PubMed ID: 17726034
[No Abstract] [Full Text] [Related]
11. Tardive dyskinesia associated with anastrozole.
Manjunatha N; Ganjekar S; Mahendra JV; Kilara N; Srinivasa R
J Neuropsychiatry Clin Neurosci; 2013; 25(3):E27-8. PubMed ID: 24026733
[No Abstract] [Full Text] [Related]
12. Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin.
Carlini P; Di Cosimo S; Ferretti G; Papaldo P; Fabi A; Ruggeri EM; Milella M; Cognetti F
Ann Oncol; 2003 Nov; 14(11):1689-90. PubMed ID: 14581280
[No Abstract] [Full Text] [Related]
13. Bupropion-induced subacute cutaneous lupus erythematosus.
Cassis TB; Callen JP
Australas J Dermatol; 2005 Nov; 46(4):266-9. PubMed ID: 16197429
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effects of anastrozole in a premenopausal breast cancer model.
Kubatka P; Sadlonová V; Kajo K; Nosál'ová G; Ostatníková D; Adamicová K
Anticancer Res; 2008; 28(5A):2819-23. PubMed ID: 19035316
[TBL] [Abstract][Full Text] [Related]
15. Subacute-cutaneous lupus erythematosus induced by Simvastatin.
Rüger RD; Simon JC; Treudler R
J Dtsch Dermatol Ges; 2011 Jan; 9(1):54-5. PubMed ID: 21040470
[No Abstract] [Full Text] [Related]
16. Case report: verapamil-induced subacute cutaneous lupus erythematosus.
Kurtis B; Larson MJ; Hoang MP; Cohen JB
J Drugs Dermatol; 2005; 4(4):506-8. PubMed ID: 16004027
[TBL] [Abstract][Full Text] [Related]
17. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide-induced subacute cutaneous lupus erythematosus.
Goëb V; Berthelot JM; Joly P; Mejjad O; de Quatrebarbes J; Reynaud-Hautin C; Vittecoq O; Le Loët X
Rheumatology (Oxford); 2005 Jun; 44(6):823-4. PubMed ID: 15757964
[No Abstract] [Full Text] [Related]
19. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
[TBL] [Abstract][Full Text] [Related]
20. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Aug; 18(8):811-21. PubMed ID: 19085975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
